Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1
Closed -$80 642
2017
Q1
$80 Sell
1
-117
-99% -$7.46K ﹤0.01% 501
2016
Q4
$7.12K Hold
118
﹤0.01% 419
2016
Q3
$7K Hold
118
﹤0.01% 428
2016
Q2
$6.58K Sell
118
-74
-39% -$3.99K ﹤0.01% 386
2016
Q1
$9.97K Hold
192
﹤0.01% 414
2015
Q4
$9.5K Hold
192
﹤0.01% 330
2015
Q3
$8.86K Sell
192
-448
-70% -$22.7K ﹤0.01% 354
2015
Q2
$36.3K Hold
640
﹤0.01% 306
2015
Q1
$35.7K Sell
640
-1,135
-64% -$65.4K ﹤0.01% 337
2014
Q4
$103K Buy
+1,775
New +$110K 0.01% 281

Other funds holding DOV

Exane Derivatives's DOV Position: Q2 2017 in Review

Exane Derivatives sold out of Dover (DOV) in Q2 2017, closing a stake of 1 share — an estimated $80 sold.

Exane Derivatives first reported a position in DOV in Q4 2014 and held it in 10 quarters. The position peaked at $103K in Q4 2014. 602 funds tracked by Wall St. Rank hold DOV as of Q2 2017.

  • Exane Derivatives reported no remaining Dover position as of Q2 2017 after selling out during the quarter.
  • Exane Derivatives sold 1 Dover share in Q2 2017, an estimated $80.
  • Exane Derivatives first reported a position in Dover in Q4 2014 and held it in 10 quarters.
  • Exane Derivatives's Dover position peaked at $103K in Q4 2014.
  • 602 funds tracked by Wall St. Rank held Dover as of Q2 2017.

Based on Exane Derivatives's 13F filing for Q2 2017, filed 17 Jul 2017.